PESAPANE, ADA
 Distribuzione geografica
Continente #
EU - Europa 81
NA - Nord America 44
AS - Asia 17
Totale 142
Nazione #
US - Stati Uniti d'America 44
IT - Italia 40
IE - Irlanda 22
SG - Singapore 15
DE - Germania 9
CZ - Repubblica Ceca 3
AT - Austria 2
CN - Cina 2
DK - Danimarca 2
FI - Finlandia 2
NL - Olanda 1
Totale 142
Città #
Santa Clara 25
Naples 23
Dublin 22
Singapore 10
Munich 6
Brno 3
New York 3
Rome 3
Chandler 2
Florence 2
Juelsminde 2
Vienna 2
Avellino 1
Aversa 1
Bremen 1
Carinaro 1
Caserta 1
Council Bluffs 1
Ercolano 1
Frankfurt am Main 1
Helsinki 1
Lappeenranta 1
Los Angeles 1
Nuremberg 1
Somma Vesuviana 1
Totale 116
Nome #
Anti-inflammatory role of SGLT2 inhibitors as part of their anti-atherosclerotic activity: Data from basic science and clinical trials 36
Targeting high glucose-induced epigenetic modifications at cardiac level: the role of SGLT2 and SGLT2 inhibitors 34
Evidence that tirzepatide protects against diabetes-related cardiac damages 17
Targeting redox imbalance in neurodegeneration: characterizing the role of GLP-1 receptor agonists 14
Tirzepatide prevents neurodegeneration through multiple molecular pathways 13
Bridging the gap between GLP1-receptor agonists and cardiovascular outcomes: evidence for the role of tirzepatide 13
Obesity-induced neuronal senescence: Unraveling the pathophysiological links 13
Combined blockade of mTOR and p21-activated kinases pathways prevents tumour growth in KRAS-mutated colorectal cancer 9
Myocardial sodium–glucose cotransporter 2 expression and cardiac remodelling in patients with severe aortic stenosis: The BIO-AS study 5
Pak1 pathway hyper-activation mediates resistance to endocrine therapy and CDK4/6 inhibitors in ER+ breast cancer 5
Totale 159
Categoria #
all - tutte 1.208
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.208


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202332 0 0 0 0 6 1 2 6 17 0 0 0
2023/202445 1 2 3 1 4 5 0 0 8 3 3 15
2024/202582 9 1 2 10 31 29 0 0 0 0 0 0
Totale 159